Goldman Sachs’s Mural Oncology MURA Stock Holding History

Goldman Sachs’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-37,712	Closed	-$78.1K	–	6695
2025 Q3	$78.1K	Buy	37,712 +15,138	+67%	+$32.5K	﹤0.01%	6119
2025 Q2	$55.8K	Sell	22,574 -87,348	-79%	-$206K	﹤0.01%	5897
2025 Q1	$139K	Sell	109,922 -5,906	-5%	-$21.5K	﹤0.01%	5722
2024 Q4	$373K	Buy	115,828 +65,642	+131%	+$231K	﹤0.01%	5401
2024 Q3	$157K	Sell	50,186 -129,421	-72%	-$421K	﹤0.01%	5509
2024 Q2	$564K	Buy	179,607 +111,989	+166%	+$413K	﹤0.01%	4765
2024 Q1	$331K	Sell	67,618 -58,590	-46%	-$284K	﹤0.01%	4929
2023 Q4	$747K	Buy	+126,208	New	+$507K	﹤0.01%	4546

Goldman Sachs's MURA Position: Q4 2025 in Review

Goldman Sachs sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 37,712 shares — an estimated $78.1K sold.

Goldman Sachs first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $747K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Goldman Sachs reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Goldman Sachs sold 37,712 Mural Oncology shares in Q4 2025, an estimated $78.1K.
Goldman Sachs first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Goldman Sachs's Mural Oncology position peaked at $747K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Goldman Sachs's 13F filing for Q4 2025, filed 10 Feb 2026.